BMY axes Seattle development team acquired from ZymoGenetics: http://www.xconomy.com/seattle/2013/11/07/bristol-myers-whacks-clinical-team-zymogenetics-seattle-site/ BMY paid $735M in cash for ZGEN in 2010.